Clinical Trials

Dr. Kim has designed a number of phase 2 clinical trials for atopic dermatitis and chronic itch. Thus, we are able to provide expertise in trial design along with employing translational assays to capture correlative biomarkers. We are continuously focused on designing new and innovative trials to champion the development of new and better treatments for chronic itch disorders.